AAPL309.18+0.55 (+0.18%) ▲|ABBV254.80-6.25 (-2.39%) ▼|ABT93.61-1.79 (-1.87%) ▼|ACN135.09-2.25 (-1.64%) ▼|ADBE216.03-3.69 (-1.68%) ▼|AMAT615.72+12.68 (+2.10%) ▲|AMD562.04+44.22 (+8.54%) ▲|AMGN361.13-13.02 (-3.48%) ▼|AMT162.48-3.53 (-2.12%) ▼|AMZN242.18-0.49 (-0.20%) ▼|AVGO381.57+21.12 (+5.86%) ▲|AXP352.38+0.42 (+0.12%) ▲|BA229.90+3.41 (+1.51%) ▲|BAC59.59+0.86 (+1.46%) ▲|BKNG183.54-1.02 (-0.55%) ▼|BLK998.89+3.16 (+0.32%) ▲|BMY56.72-1.41 (-2.43%) ▼|BNY149.50+2.88 (+1.96%) ▲|BRK-B505.39-2.39 (-0.47%) ▼|C142.71+2.74 (+1.96%) ▲|CAT985.78+22.25 (+2.31%) ▲|CL92.65-2.48 (-2.61%) ▼|CMCSA23.45-0.35 (-1.45%) ▼|COF206.39+1.27 (+0.62%) ▲|COP104.39-0.34 (-0.32%) ▼|COST943.81-7.87 (-0.83%) ▼|CRM165.45-0.66 (-0.40%) ▼|CSCO114.51+1.82 (+1.62%) ▲|CVS103.44-1.28 (-1.22%) ▼|CVX168.77-0.43 (-0.25%) ▼|DE620.74-0.54 (-0.09%) ▼|DHR191.53-6.40 (-3.23%) ▼|DIS97.55-1.95 (-1.96%) ▼|DUK127.70-1.91 (-1.47%) ▼|EMR141.27+2.22 (+1.60%) ▲|FDX315.80+2.80 (+0.89%) ▲|GD372.78-0.76 (-0.20%) ▼|GE375.58-1.48 (-0.39%) ▼|GEV1,189.67+76.56 (+6.88%) ▲|GILD128.66-2.61 (-1.99%) ▼|GM77.08+1.08 (+1.41%) ▲|GOOG354.41-1.77 (-0.50%) ▼|GOOGL357.63-2.28 (-0.63%) ▼|GS1,044.44+23.44 (+2.30%) ▲|HD348.40-9.50 (-2.65%) ▼|HON227.30-2.56 (-1.11%) ▼|IBM295.43+5.91 (+2.04%) ▲|INTC125.17+4.82 (+4.01%) ▲|INTU271.46-3.89 (-1.41%) ▼|ISRG422.59-3.42 (-0.80%) ▼|JNJ256.86-6.18 (-2.35%) ▼|JPM336.88+3.91 (+1.17%) ▲|KO82.99-1.15 (-1.37%) ▼|LIN536.00-10.64 (-1.95%) ▼|LLY1,189.10-24.81 (-2.04%) ▼|LMT539.40-6.51 (-1.19%) ▼|LOW221.18-6.32 (-2.78%) ▼|LRCX360.97+9.56 (+2.72%) ▲|MA525.81-13.59 (-2.52%) ▼|MCD276.08-4.56 (-1.62%) ▼|MDLZ59.56-1.35 (-2.22%) ▼|MDT82.04-1.16 (-1.39%) ▼|META584.19+1.29 (+0.22%) ▲|MMM158.55-1.89 (-1.18%) ▼|MO71.59-1.12 (-1.54%) ▼|MRK126.34-3.22 (-2.49%) ▼|MS219.27+5.34 (+2.50%) ▲|MSFT385.25-5.24 (-1.34%) ▼|MU994.96+19.40 (+1.99%) ▲|NEE87.39-0.95 (-1.08%) ▼|NFLX76.14-1.51 (-1.94%) ▼|NKE42.74-1.36 (-3.07%) ▼|NOW107.75+1.43 (+1.35%) ▲|NVDA196.53+1.70 (+0.87%) ▲|ORCL142.69+2.42 (+1.73%) ▲|PEP141.97-2.26 (-1.56%) ▼|PFE23.77-0.55 (-2.28%) ▼|PG147.76-3.65 (-2.41%) ▼|PLTR131.42+2.12 (+1.64%) ▲|PM182.20-0.08 (-0.04%) ▼|QCOM186.63+10.38 (+5.89%) ▲|RTX199.39+0.14 (+0.07%) ▲|SBUX101.74-2.54 (-2.43%) ▼|SCHW97.96+0.96 (+0.99%) ▲|SO96.70-1.28 (-1.31%) ▼|SPG223.90-2.16 (-0.96%) ▼|T20.42-0.17 (-0.80%) ▼|TMO511.42-12.02 (-2.30%) ▼|TMUS179.94+2.42 (+1.36%) ▲|TSLA403.09+9.64 (+2.45%) ▲|TXN304.37+11.29 (+3.85%) ▲|UBER73.34-1.09 (-1.46%) ▼|UNH416.47-8.89 (-2.09%) ▼|UNP282.41+0.16 (+0.05%) ▲|UPS110.12-0.54 (-0.49%) ▼|USB62.67+0.94 (+1.52%) ▲|V350.58-11.55 (-3.19%) ▼|VZ42.24-0.32 (-0.75%) ▼|WFC86.55+1.04 (+1.22%) ▲|WMT110.82-1.02 (-0.91%) ▼|XOM136.70-0.39 (-0.28%) ▼|AAPL309.18+0.55 (+0.18%) ▲|ABBV254.80-6.25 (-2.39%) ▼|ABT93.61-1.79 (-1.87%) ▼|ACN135.09-2.25 (-1.64%) ▼|ADBE216.03-3.69 (-1.68%) ▼|AMAT615.72+12.68 (+2.10%) ▲|AMD562.04+44.22 (+8.54%) ▲|AMGN361.13-13.02 (-3.48%) ▼|AMT162.48-3.53 (-2.12%) ▼|AMZN242.18-0.49 (-0.20%) ▼|AVGO381.57+21.12 (+5.86%) ▲|AXP352.38+0.42 (+0.12%) ▲|BA229.90+3.41 (+1.51%) ▲|BAC59.59+0.86 (+1.46%) ▲|BKNG183.54-1.02 (-0.55%) ▼|BLK998.89+3.16 (+0.32%) ▲|BMY56.72-1.41 (-2.43%) ▼|BNY149.50+2.88 (+1.96%) ▲|BRK-B505.39-2.39 (-0.47%) ▼|C142.71+2.74 (+1.96%) ▲|CAT985.78+22.25 (+2.31%) ▲|CL92.65-2.48 (-2.61%) ▼|CMCSA23.45-0.35 (-1.45%) ▼|COF206.39+1.27 (+0.62%) ▲|COP104.39-0.34 (-0.32%) ▼|COST943.81-7.87 (-0.83%) ▼|CRM165.45-0.66 (-0.40%) ▼|CSCO114.51+1.82 (+1.62%) ▲|CVS103.44-1.28 (-1.22%) ▼|CVX168.77-0.43 (-0.25%) ▼|DE620.74-0.54 (-0.09%) ▼|DHR191.53-6.40 (-3.23%) ▼|DIS97.55-1.95 (-1.96%) ▼|DUK127.70-1.91 (-1.47%) ▼|EMR141.27+2.22 (+1.60%) ▲|FDX315.80+2.80 (+0.89%) ▲|GD372.78-0.76 (-0.20%) ▼|GE375.58-1.48 (-0.39%) ▼|GEV1,189.67+76.56 (+6.88%) ▲|GILD128.66-2.61 (-1.99%) ▼|GM77.08+1.08 (+1.41%) ▲|GOOG354.41-1.77 (-0.50%) ▼|GOOGL357.63-2.28 (-0.63%) ▼|GS1,044.44+23.44 (+2.30%) ▲|HD348.40-9.50 (-2.65%) ▼|HON227.30-2.56 (-1.11%) ▼|IBM295.43+5.91 (+2.04%) ▲|INTC125.17+4.82 (+4.01%) ▲|INTU271.46-3.89 (-1.41%) ▼|ISRG422.59-3.42 (-0.80%) ▼|JNJ256.86-6.18 (-2.35%) ▼|JPM336.88+3.91 (+1.17%) ▲|KO82.99-1.15 (-1.37%) ▼|LIN536.00-10.64 (-1.95%) ▼|LLY1,189.10-24.81 (-2.04%) ▼|LMT539.40-6.51 (-1.19%) ▼|LOW221.18-6.32 (-2.78%) ▼|LRCX360.97+9.56 (+2.72%) ▲|MA525.81-13.59 (-2.52%) ▼|MCD276.08-4.56 (-1.62%) ▼|MDLZ59.56-1.35 (-2.22%) ▼|MDT82.04-1.16 (-1.39%) ▼|META584.19+1.29 (+0.22%) ▲|MMM158.55-1.89 (-1.18%) ▼|MO71.59-1.12 (-1.54%) ▼|MRK126.34-3.22 (-2.49%) ▼|MS219.27+5.34 (+2.50%) ▲|MSFT385.25-5.24 (-1.34%) ▼|MU994.96+19.40 (+1.99%) ▲|NEE87.39-0.95 (-1.08%) ▼|NFLX76.14-1.51 (-1.94%) ▼|NKE42.74-1.36 (-3.07%) ▼|NOW107.75+1.43 (+1.35%) ▲|NVDA196.53+1.70 (+0.87%) ▲|ORCL142.69+2.42 (+1.73%) ▲|PEP141.97-2.26 (-1.56%) ▼|PFE23.77-0.55 (-2.28%) ▼|PG147.76-3.65 (-2.41%) ▼|PLTR131.42+2.12 (+1.64%) ▲|PM182.20-0.08 (-0.04%) ▼|QCOM186.63+10.38 (+5.89%) ▲|RTX199.39+0.14 (+0.07%) ▲|SBUX101.74-2.54 (-2.43%) ▼|SCHW97.96+0.96 (+0.99%) ▲|SO96.70-1.28 (-1.31%) ▼|SPG223.90-2.16 (-0.96%) ▼|T20.42-0.17 (-0.80%) ▼|TMO511.42-12.02 (-2.30%) ▼|TMUS179.94+2.42 (+1.36%) ▲|TSLA403.09+9.64 (+2.45%) ▲|TXN304.37+11.29 (+3.85%) ▲|UBER73.34-1.09 (-1.46%) ▼|UNH416.47-8.89 (-2.09%) ▼|UNP282.41+0.16 (+0.05%) ▲|UPS110.12-0.54 (-0.49%) ▼|USB62.67+0.94 (+1.52%) ▲|V350.58-11.55 (-3.19%) ▼|VZ42.24-0.32 (-0.75%) ▼|WFC86.55+1.04 (+1.22%) ▲|WMT110.82-1.02 (-0.91%) ▼|XOM136.70-0.39 (-0.28%) ▼|
20.7 C
New York
Monday, July 6, 2026

Tag: as

newssourceFORcompanyinformationcontent1releasesmarket

Vi Appoints Spencer Honeyman as President, Global Growth

NEW YORK, June 7, 2026 /PRNewswire/ -- Vi today announced the promotion of Spencer Honeyman to President, Global Growth. ...

Xinhua Silk Road: Posidonia China Night provides high-level platform for int’l maritime exchange, cooperation

BEIJING, June 7, 2026 /PRNewswire/ -- Posidonia China Night, held in Athens during the Posidonia 2026, one of the world's leading maritime exhibitions, brought...

Barclays Investor News: If You Have Suffered Losses in Barclays PLC (NYSE: BCS), You Are Encouraged to Contact The Rosen Law Firm About Your...

NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public.

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 7, 2026 /CNW/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of...

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 7, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of...

Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of...

Anamana Incubator Targets Culturally Native Creators to Diversify Homogenized Micro-Drama Market

AI-native micro-serial platform invests in culture-driven stories made by insiders to differentiate from global ROI-driven legacy platformsSINGAPORE, June 7, 2026 /PRNewswire/ -- Anamana, the...

The 34th Eye Level Literary Awards Opens Global Literary Submissions

SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Daekyo Culture Foundation and the World Youth Culture Foundation announce the opening of submissions for the 34th...

Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program

SAN DIEGO, June 8, 2026 /PRNewswire/ -- Sapu Bioscience LLC announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for...

Ascletis Reinforces Its Differentiated Obesity Portfolio at American Diabetes Association (ADA) 2026 Scientific Sessions, Showcasing ASC30 Clinical Data and Exciting Preclinical Findings from ASC37...

HONG KONG, June 7, 2026 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces the presentation of three key studies at the American Diabetes...

BLACKYAK Hosts “Himalayan Climate Charter 2026: Namche Summit” to Advance Global Climate Action

- Highlights the climate crisis facing the Himalayas and underscores the need for international solidarity and collective action- Held in Namche Bazaar, Nepal, the...

GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company

Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas 
Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas

Australian Retirees Seek Reliable Monthly Income From Global Private Credit as Inflation Bites and TermPlus Targets Up To 8.50%* Per Annum

Sydney, Australia, June 07, 2026 (GLOBE NEWSWIRE) -- With annual inflation at 4.6% in the year to March 2026 and roughly 4.4 million Australians now aged 65 and over, retirees face a sharpening challenge: turning a lifetime of savings into income that keeps pace with the rising cost of groceries, fuel and everyday essentials. The pressure is compounded by longevity, with many Australians spending two or even three decades in retirement, and by a shift in mindset that retirement itself demands. In the accumulation years, investors can ride out market volatility and recover losses over time; in the drawdown phase, with shorter horizons and less capacity to recoup losses, the priority moves to predictable income and preserving purchasing power. To learn more visit https://termplus.com.au/insights-news/news/turning-savings-into-reliable-monthly-income-in-retirement/

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China

The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAs

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers